Literature DB >> 9673228

Evaluation of the proline-rich antigen of Coccidioides immitis as a vaccine candidate in mice.

T N Kirkland1, F Finley, K I Orsborn, J N Galgiani.   

Abstract

We have expressed the proline-rich antigen (PRA) from Coccidioides immitis in Escherichia coli and evaluated its potential as a vaccine candidate. Sodium dodecyl sulfate-polyacrylamide gel electrophoresis analysis of the recombinant protein (rPRA) revealed two bands, which exhibited virtually identical primary amino acid sequences. T cells from rPRA-immunized BALB/c mice showed a significant in vitro proliferative response to rPRA. A small but statistically significant proliferative response was also induced by rPRA in T cells from mice immunized with whole-cell coccidioidal vaccines. BALB/c mice immunized with rPRA and challenged intraperitoneally with virulent C. immitis had a greatly reduced fungal burden in their lungs and spleens compared to unvaccinated mice. The number of organisms in the lungs was reduced 500-fold, and similar reductions were observed in the spleens of immunized mice. These studies support the continued development of rPRA as a candidate vaccine for prevention of coccidioidomycosis.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9673228      PMCID: PMC108381     

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  28 in total

1.  Pattern of 39,500 serologic tests in coccidioidomycosis.

Authors:  C E SMITH; M T SAITO; S A SIMONS
Journal:  J Am Med Assoc       Date:  1956-02-18

2.  Production of a murine monoclonal antibody that recognizes an epitope specific to Coccidioides immitis antigen 2.

Authors:  R A Cox; M J Dolan; D M Magee; J N Galgiani
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

3.  Cloning and sequence analysis of the cDNA for a protein from Coccidioides immitis with immunogenic potential.

Authors:  K O Dugger; K M Villareal; A Ngyuen; C R Zimmermann; J H Law; J N Galgiani
Journal:  Biochem Biophys Res Commun       Date:  1996-01-17       Impact factor: 3.575

4.  slyD, a host gene required for phi X174 lysis, is related to the FK506-binding protein family of peptidyl-prolyl cis-trans-isomerases.

Authors:  W D Roof; S M Horne; K D Young; R Young
Journal:  J Biol Chem       Date:  1994-01-28       Impact factor: 5.157

5.  Coccidioides immitis vaccine: potential of an alkali-soluble, water-soluble cell wall antigen.

Authors:  G Lecara; R A Cox; R B Simpson
Journal:  Infect Immun       Date:  1983-01       Impact factor: 3.441

6.  Anhydrous hydrogen fluoride deglycosylates glycoproteins.

Authors:  A J Mort; D T Lamport
Journal:  Anal Biochem       Date:  1977-10       Impact factor: 3.365

7.  Immunization of mice against coccidioidomycosis with a subcellular vaccine.

Authors:  D Pappagianis; R Hector; H B Levine; M S Collins
Journal:  Infect Immun       Date:  1979-07       Impact factor: 3.441

8.  Coccidioidomycosis during human immunodeficiency virus infection. A review of 77 patients.

Authors:  D G Fish; N M Ampel; J N Galgiani; C L Dols; P C Kelly; C H Johnson; D Pappagianis; J E Edwards; R B Wasserman; R J Clark
Journal:  Medicine (Baltimore)       Date:  1990-11       Impact factor: 1.889

9.  Inbred mouse strains differ in resistance to lethal Coccidioides immitis infection.

Authors:  T N Kirkland; J Fierer
Journal:  Infect Immun       Date:  1983-06       Impact factor: 3.441

10.  Marked increase in cases of coccidioidomycosis in California: 1991, 1992, and 1993.

Authors:  D Pappagianis
Journal:  Clin Infect Dis       Date:  1994-08       Impact factor: 9.079

View more
  23 in total

1.  Coadministration of interleukin 12 expression vector with antigen 2 cDNA enhances induction of protective immunity against Coccidioides immitis.

Authors:  C Jiang; D M Magee; R A Cox
Journal:  Infect Immun       Date:  1999-11       Impact factor: 3.441

2.  Molecular cloning of an immunogenic protein of Baylisascaris procyonis and expression in Escherichia coli for use in developing improved serodiagnostic assays.

Authors:  Sriveny Dangoudoubiyam; Ramesh Vemulapalli; Kathy Hancock; Kevin R Kazacos
Journal:  Clin Vaccine Immunol       Date:  2010-10-06

Review 3.  Measurement of cellular immunity in human coccidioidomycosis.

Authors:  Neil M Ampel
Journal:  Mycopathologia       Date:  2003       Impact factor: 2.574

4.  A major cell surface antigen of Coccidioides immitis which elicits both humoral and cellular immune responses.

Authors:  C Y Hung; N M Ampel; L Christian; K R Seshan; G T Cole
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

5.  Genetic vaccination against Coccidioides immitis: comparison of vaccine efficacy of recombinant antigen 2 and antigen 2 cDNA.

Authors:  C Jiang; D M Magee; T N Quitugua; R A Cox
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

6.  Recombinant urease and urease DNA of Coccidioides immitis elicit an immunoprotective response against coccidioidomycosis in mice.

Authors:  K Li; J J Yu; C Y Hung; P F Lehmann; G T Cole
Journal:  Infect Immun       Date:  2001-05       Impact factor: 3.441

Review 7.  A review of innate and adaptive immunity to coccidioidomycosis.

Authors:  Chiung-Yu Hung; Amy P Hsu; Steven M Holland; Joshua Fierer
Journal:  Med Mycol       Date:  2019-02-01       Impact factor: 4.076

Review 8.  Coccidioidomycosis: host response and vaccine development.

Authors:  Rebecca A Cox; D Mitchell Magee
Journal:  Clin Microbiol Rev       Date:  2004-10       Impact factor: 26.132

9.  Evaluation of two homologous proline-rich proteins of Coccidioides posadasii as candidate vaccines against coccidioidomycosis.

Authors:  Roger A Herr; Chiung-Yu Hung; Garry T Cole
Journal:  Infect Immun       Date:  2007-09-17       Impact factor: 3.441

Review 10.  Influence of host genetics on the severity of coccidioidomycosis.

Authors:  L Louie; S Ng; R Hajjeh; R Johnson; D Vugia; S B Werner; R Talbot; W Klitz
Journal:  Emerg Infect Dis       Date:  1999 Sep-Oct       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.